Today CNBX ranks # as SELL CANDIDATE.
Today CNBX ranks # as SELL CANDIDATE.

CNBX stock Cannabics Pharma

CNBX stock
Cannabics Pharma

April 24, 2019
Change -1.38%
Chart period: 2019-01-25 - 2019-04-24
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Buy

MACD
Buy

Will CNBX stock price go up or down on Fri, 26 Apr 2019?

Cannabics Pharma Forecast and Stock Analysis

Technical CNBX stock analysis for April 24, 2019.

Sell candidate since 2019-04-18 Loss -6.86%

Cannabics Pharma fell by -1.38% in the last day from $0.34 to $0.34 The price has fallen in 5 of the last 10 days and is down by -1.38% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -8 480 shares and in total 35 734 shares bought and sold for approximately $11 981.60.

Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the CNBX stock was $0.34. This is 1.38% less than the trading day before Tuesday, 23rd Apr 2019.

During day the stock fluctuated 9.90% from a day low at $0.33 to a day high of $0.36.

30 day high of the CNBX stock price was $0.40 and low was $0.33.
90 day high was $0.50 and low was $0.32.
52 week high for the Cannabics Pharma - $1.35 and low - $0.27.

Trend

Cannabics Pharma lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -24.03% during the next 3 months and, with 90% probability hold a price between $0.23 and $0.27 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Monday April 22, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Cannabics Pharma holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.35 and $0.36. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 40 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Cannabics Pharma finds support from accumulated volume at $0.34.

Support: $0.34 Price: $0.34 Resistance: $0.34

Risk

In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Today CNBX ranks # as SELL CANDIDATE.
Today CNBX ranks # as SELL CANDIDATE.